Neuropeptide Y: Emerging evidence for a functional role in seizure modulation

Trends in Neurosciences

Volumn 22, Issue 1, 1999, Pages 25-30

  Vezzani, Annamaria ^a   Sperk, Günther ^b   Colmers, William F ^c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

KAINIC ACID; NEUROPEPTIDE Y;

CARDIOVASCULAR AUTOREGULATION; ELECTROPHYSIOLOGY; FOOD INTAKE; HIPPOCAMPUS; HUMAN; IMMUNOREACTIVITY; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SEIZURE; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION; TRANQUILIZING ACTIVITY;

EID: 0033057715     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(98)01284-3     Document Type: Review

References (65)

1. Allen, J.M. and Koenig, J.I., Eds (1990) Ann. New York Acad. Sci. 611
2. Michel, M. et al. (1998) Pharmacol Rev. 50, 143-150
3. Bartfai, T. et al. (1988) Annu. Rev. Pharmacol. Toxicol. 28, 285-310
4. Hökfelt, T. (1991) Neuron 7, 867-879
5. Allen, Y.S. et al. (1983) Science 221, 877-879
6. Schwarzer, C. et al. (1996) Brain Res. Rev. 22, 27-50
7. Schwarzer, C. et al (1995) Neuroscience 69, 831-845
8. Sloviter, R.S. (1991) Hippocampus 1, 41-66
9. Sperk, G. et al. (1992) Neuroscience 50, 831-846
10. Causing, C.G. et al. (1996) J. Comp. Neurol. 367, 132-146
11. White, J.D. and Gall, C.M. (1987) Mol. Brain Res. 3, 21-29
12. Marksteiner, J., Sperk, G. and Maas, D. (1989) Naunyn-schmiedeberg's Arch. Pharmacol. 339, 173-177
13. Bellmann, R. et al. (1991) J. Neurochem. 56, 525-530
14. Gruber, B. et al. (1994) Hippocampus 4, 474-482
15. Stenfors, C., Theodorsson, E. and Mathé, A.A. (1989) J. Neurosci. Res. 24, 445-450
16. Bendotti, C. et al. (1991) Neurosci. Lett. 132, 175-178
17. Rizzi, M. et al. (1993) Eur. J. Neurosci. 5, 1534-1538
18. Sadamatsu, A. et al. (1995) Life Sci. 57, 523-531
19. Köhler, C. et al (1986) J. Comp. Neurol. 244, 384-400
20. Scharfman, H.E. (1991) J. Neurosci. 11, 1660-1673
21. Nawa, H. et al. (1994) J. Neurosci.. 14, 3751-3765
22. Gall, C.M. et al. (1993) Exp. Neurol. 124, 150-166
23. Elmér, E. et al. (1998) Neuroscience 83, 351-362
24. Schwarzer, C. and Sperk, G. (1998) Hippocampus 8, 1-15
25. Sperk, G. (1994) Prag. Neurobiol. 42, 1-32
26. Zachrisson, O. et al. (1995) Mol. Brain Res. 31, 71-85
27. Milner, T.A. et al. (1997) J. Comp. Neurol. 386, 46-59
28. Schwarzer, C. et al. (1996) Naunyn-Schmiedeberg's Arch. Pharmacol. 354, 67-71
29. Johansen, F.F. (1993) Acta Neurol. Scand. 88, 1-32
30. Sloviter, R.S. (1987) Science 235, 73-76
31. DeLanerolle, N.C. et al. (1989) Brain Res. 495, 387-395
32. Houser, C.R. et al (1990) J. Neurosci. 10, 267-282
33. Dumont, Y. et al. (1993) J. Neurosci. 13, 73-86
34. Colmers, W.F. and Bleakman, D. (1994) Trends Neurosci. 17, 373-379
35. Qian, J., Colmers, W.F. and Saggau, P. (1997) J Neurosci. 17, 8169-8177
36. Schwarzer, C., Kofler, N. and Sperk, G. (1998) Mol. Pharmacol. 53, 6-13
37. Gobbi, M. et al. (1998) J. Neurochem. 70, 1615-1622
38. Gustafson, E.L. et al. (1997) Mol Brain Res. 46, 223-235
39. Gobbi, M. et al. (1996) Neuroreport 7, 1475-1480
40. Kofler, N. et al. (1997) Neurosci. Lett. 230, 129-132
41. Larsen, P.J. et al. (1993) Eur. J. Neurosci. 5, 1622-1637
42. Widowson, P.S., Buckingham, R. and Williams, G. (1997) Brain Res. 778, 242-250
43. Rôder, C. et al. (1996) Neuroscience 70, 47-55
44. Greber, S., Schwarzer, C. and Sperk, G. (1994) Br. J. Pharmacol. 113, 737-740
45. Vezzani, A. et al (1994) Brain Res. 660, 138-143
46. Klapstein, G.J. and Colmers, W.F. (1993) Hippocampus 3, 103-112
47. Colmers, W.F. et al (1997) Epilepsia 38 (Suppl. 8), 12
48. Colmers, W.F., Lukowiak, K. and Pittmann, Q.J. (1988) J. Neurosci. 8, 3827-3837
49. Klapstein, G.J. and Colmers, W.F. (1997) J. Neurophysiol. 78, 1651-1661
50. Brooks, P.A. et al (1987) Brain Res. 408, 295-298
51. McQuiston, A.R. et al (1996) J. Neurosci. 15, 1422-1429
52. Simmons, M.L., Terman, G.W. and Chavkin, C. (1997) J. Neurophysiol. 78, 1860-1868
53. Smialowska, M. et al (1996) Neuropeptides 30, 7-12
54. Woldbye, D.P.D. et al (1996) Brain Res. 737, 162-168
55. Erickson, J.C., Clegg, K.E. and Palmiter, R.D. (1996) Nature 386, 415-418
56. Baraban, S.C. et al (1997) J. Neurosci. 17, 8927-8936
57. Woldbye, D.P.D. et al (1997) Nat. Med. 3, 761-764
58. Gariboldi, M. et al (1998) Eur. J. Neurosci. 10, 757-759
59. Rudolf, K. et al (1994) Eur. J. Pharmacol. 271, R11-R13
60. Frush, D.P. and McNamara, J.O. (1986) Exp. Neurol. 92, 102-113
61. Abdulla, F.A. and Smith, P.A. (1997) J. Neurosci. 17, 1633-1641
62. Jacques, D. et al (1997) Neuroscience 79, 129-148
63. Grundemar, L. and Bloom, S.R. (1997) in Neuropeptide Y and Drug Development (Grundemar, L. and Bloom, S.R., eds), p. 209, Academic Press
64. Jacques, D. et al (1998) Mol. Brain Res. 61, 100-107
65. Dumont, Y., Fournier, A. and Quirion, R. (1998) J. Neurosci. 18, 5565-5574